Folates in the treatment of depression;Folate in der Depressionsbehandlung

Fortschritte der Neurologie Psychiatrie

Volumn 82, Issue 2, 2014, Pages 78-83

  Erbe, S ^a   Pellert, U N ^b  

^a Department of Neurology   (Germany)

^b Schlosspark Klinik   (Germany)

Author keywords

augmentation; depression; folic acid; L methylfolate; MTHFR

Indexed keywords

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED;

EID: 84893952369     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0033-1356123     Document Type: Article

References (58)

1. Brönstrup A. Folat und Folsäure - Herausforderung für die Praxis. Ernährungs Umschau: 2007; 9 538 544
2. Steinberg S. E., Campbell C. L., Hillman R. S. Kinetics of the normal folate enterohepatic cycle. J Clin Invest: 1979; 64 83 88 (Pubitemid 9216522)
3. Halsted C. H. The intestinal absorption of folates. Am J Clin Nutr: 1979; 32 846 855 (Pubitemid 9164733)
4. Stahl A., Heseker H. Folat - Physiologie, Vorkommen, Analytik, Referenzwerte und Versorgung in Deutschland. Ernährungs Umschau: 2007; 6 336 343
5. Antony A. C. Folate receptors. Annu Rev Nutr: 1996; 16 501 521 (Pubitemid 26286863)
6. Deutsche Gesellschaft für Ernährung Referenzwerte für die Nährstoffzufuhr. D-A-CH Referenzwerte der DGE, ÖGE, SGE/SVE (23.06.2004). Im Internet: www.dge.de Stand: 03.09.2013
7. Nationale Verzehrsstudie II (NVS II), herausgegeben vom Max-Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel, im Auftrag des Bundesministeriums für Ernährung, Landwirtschaft und Verbraucherschutz (2008). Im Internet: www.mri.bund.de; Stand: 03.09.2013
8. Stahl S. M. Novel therapeutics for depression: l-methylfolate as a trimonamine modulator and antidepressant-augmenting agent. CNS Spectr: 2007; 12 739 744 (Pubitemid 350072170)
9. Stahl S. M. L-methylfolate: a vitamin for your monoamines. J Clin Psychiatry: 2008; 69 1352 1353
10. Paslakis G., Bleich S., Frieling H. et al. Epigenetische Mechanismen der Depression. Nervenarzt: 2011; 82 1431 1439
11. Peedicayil J. Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders. J Clin Pharm Ther: 2012; 37 499 501
12. Farah A. The role of l-methylfolate in depressive disorders. CNS spectr: 2009; 14 2 7
13. Alpert M., Silva R. R., Pouget E. R. Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant. J Clin Psychopharmacol: 2003; 23 309 313 (Pubitemid 36807797)
14. Bottigleri T. Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry: 2005; 29 1103 1112
15. Papakostas G. I., Iosifescu D. V., Renshaw P. F. et al. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II). Psychiatry Res: 2005; 140 301 307 (Pubitemid 41660974)
16. Levitt A. J., Joffe R. T. Folate, B12, and life course of depressive illness. Biol Psychiatry: 1989; 25 867 872 (Pubitemid 19122762)
17. Alpert J. E., Fava M. Nutrition and depression: the role of folate. Nutr Rev: 1997; 55 145 149 (Pubitemid 27331379)
18. Wesson V. A., Levitt A. J., Joffe R. T. Change in folate status with antidepressant treatment. Psychiatry Res: 1994; 53 313 122
19. Coppen A., Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol: 2005; 19 59 65
20. Abou-Saleh M. T., Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand: 1989; 80 78 82 (Pubitemid 19179480)
21. Reynolds E. H., Preece J. M., Bailey J. et al. Folate deficiency in depressive illness. Br J Psychiatry: 1970; 117 287 292
22. Folstein M., Liu T., Peter I. et al. The homocysteine hypothesis of depression. Am J Psychiatry: 2007; 164 861 867 (Pubitemid 46978110)
23. Bottiglieri T., Hyland K., Laundry M. et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med: 1992; 22 871 876 (Pubitemid 23006998)
24. Fava M., Rush A. J., Trivedi M. H. et al. Background and rationale for the Sequenced treatment alternatives to relieve depression (STARD) study. Psych Clin North Amer: 2003; 26 457 494 (Pubitemid 36583573)
25. Hardeveld F., Spijker J., De Graaf R. et al. Prevalence and predictors of recurrence of major depressive disorder in adult population. Acta Psychiatr Scand: 2010; 122 184 191
26. Kang S. S., Zhou J., Wong P. W. et al. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am j Hum Genet: 1988; 43 414 421
27. Tan E. C., Chong S. A., Lim L. C. et al. Genetic analysis of thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet: 2004; 14 227 231 (Pubitemid 40054351)
28. Gilbody S., Lewis S., Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol: 2007; 165 1 13 (Pubitemid 46026203)
29. Cortese C., Motti C. MTHFR gene polymorphism, homocysteine and cardiovascular disease. Public Health Nutr: 2001; 4 493 497 (Pubitemid 32524571)
30. Bjelland I., Tell G. S., Vollset S. E. et al. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry: 2003; 60 618 626 (Pubitemid 36682319)
31. Arinami T., Yamada N., Yamakawa-Kobayashi K. et al. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet: 1997; 74 526 528 (Pubitemid 27424220)
32. Hickie I., Scott E., Naismith S. et al. Late-onset depression: genetic vascular and clinical contributions. Psychol Med: 2001; 31 1403 1412 (Pubitemid 33040364)
33. Kunugi H., Fukuda R., Hattori M. et al. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychosis variant. Mol Psychiatry: 1998; 3 435 437 (Pubitemid 28442418)
34. Reif A., Pfuhlmann B., Lesch K. P. Homocysteine as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry: 2005; 29 1162 1168 (Pubitemid 41383515)
35. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphism in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psych Genet: 2006; 16 105 115 (Pubitemid 44502772)
36. Godfrey P. S., Toone B. K., Carney M. W. et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet: 1990; 336 392 395 (Pubitemid 20252436)
37. Passeri M., Cucinotta D., Abate G. et al. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano): 1993; 5 63 71 (Pubitemid 23117911)
38. Peerbooms O. LJ, van Os J., Drukker M. et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability? Brain Behav Immun: 2011; 25 1530 1543
39. Crellin R., Bottiglieri T., Reynolds E. H. Folates and psychiatric disorders: clinical potential. Drugs: 1993; 45 623 636 (Pubitemid 23177439)
40. Leeming R. J. Enhancement of recovery from psychiatric illness by methylfolate. Lancet: 1990; 336 953 954 (Pubitemid 20351232)
41. Procter A. Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry: 1991; 159 271 272
42. Anderson D., Wilkinson A., Abou-Saleh M. et al. Enhancement of recovery from psychiatric illness by methylfolate. Br J Psychiatry: 1992; 160 130
43. Wing Y. K., Lee S. Methylfolate and psychiatric illness. Br J Psychiatry: 1992; 160 714 715
44. Coppen A., Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord: 2000; 60 121 130
45. Resler G., Lavie R., Campos J. et al. Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes. Neuroimmunomodulation: 2008; 15 145 152
46. Coppen A., Chaudhry S. SC. Folic acid enhances lithium prophylaxis. J Affect Disord: 1986; 10 9 13 (Pubitemid 16109820)
47. Fava M., Evins A. E., Dorer D. J. et al. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom: 2003; 72 115 127 (Pubitemid 36469860)
48. Papakostas G. I., Shelton R. C., Zajecka J. M. et al. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry: 2012; 169 1267 1274
49. Bauer M., Dopfmer S. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol: 1999; 19 427 434 (Pubitemid 29451507)
50. Nelson J. C., Papakostas G. I. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry: 2009; 166 980 991
51. Bauer M., Adli M., Bschor T. et al. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology: 2010; 62 36 42
52. Erbe S., Gutwinski S., Bschor T. Augmentation von Antidepressiva mit atypischen Antipsychotika bei Nonresponse auf eine Antidepressiva-Monotherapie. Eine systematische Übersichtsarbeit randomisierter placebokontrollierter Studien bei unipolarer nicht wahnhafter Depression. Psychiat Prax: 2012; 39 57 63
53. Papakostas G. I., Cassiello C. F., Iovieno N. Folates and s-adenosylmethionine for major depressive disorder. Can J Psychiatry: 2012; 57 406 413
54. Shelton R. C., Manning J. S., Barrentine L. W. et al. Assessing effects of l-methylfolate in depression management: results of a real-world patient experience trial. Prim Care Companion CNS Disord: 2013; 15 10.4088/PCC.13m01520
55. Mischoulon D., Fava M., Stahl S. M. In reply to: Frankenburg FR. Folate supplementation: is it safe and effective [letter]? J Clin Psychiatry: 2009; 70 767 769
56. Greenberg J. A., Bell S. J. Multivitamin supplementation during pregnancy: emphasis on folic acid and l-methylfolate. Rev Obstet Gynecol: 2011; 4 126 127
57. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Hrsg) für die Leitliniengruppe Unipolare Depression* S3-Leitlinie/Nationale Versorgungsleitlinie Unipolare Depression. 1. Aufl Berlin, Düsseldorf DGPPN, ÄZQ, AWMF Internet: 2009; www.dgppn.dewww.versorgungsleitlinien.de www.awmf-leitlinien.de (Organisationen, die in der Leitliniengruppe kooperierten: DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, BDK, BDP, BPM, BVDN, BVDP, BVVP, CPKA, DÄVT, DFT, DGGPP, DGPT, DGVT, DPG, DPV, DPtV, DVT, Deutscher Hausärzteverband, GwG, KND)
58. American Psychiatric Association (APA) Practice guideline for the treatment of patients with major depressive disorder. 3rd ed Arlington (VA) American Psychiatric Association (APA): 2010; 152 [1170 references]